Tissue homogenates from 60 specimens submitted to the Veterinary Diagnostic Center were evaluated by polymerase chain reaction (PCR) for detection of bovine viral diarrhea virus (BVDV). Conventional virus isolation procedures showed the specimens contained BVDV. The BVDV RNA was extracted from the homogenates and subjected to a reverse transcription reaction followed by PCR amplification. The PCR product was blotted onto a nylon membrane and hybridized with a 30-base pair oligonucleotide probe labeled with 32 P. One set of PCR primers detected BVDV in 46/60 (77%) of the tissue homogenates. An additional set of primers was used to detect 10/11 samples that had escaped detection with the first set of primers. The results indicate that BVDV can be detected by PCR directly out of tissue homogenates generated in a diagnostic setting.
Bovine viral diarrhea virus (BVDV) is an important using the polymerase chain reaction (PCR) techpathogen of cattle causing a variety of diseases that nique. 1,2,5,6,10,11, 15, 23, 24, 26 range in severity from mild inapparent infections to Application of PCR in a diagnostic setting requires fatal mucosal disease. 20, 21 BVDV is classified within adaptation for use on clinical samples. Previous reports the family Flaviviridae and is a member of the genus on the use of PCR for detection of BVDV have not Pestivirus. The viral genome consists of a single-strandaddressed the problems associated with clinical speced nonpolyadenylated RNA about 12.5 kb in length. 8 imens. The purpose of this study was to evaluate PCR Isolates of BVDV are divided into 2 biotypes, cytodetection of BVDV in field specimens using primers 15, 22 that amplify sequences near opposite ends of the BVDV genome.
pathic and noncytopathic, based on effects in cell culture. 25 Infections of cattle with noncytopathic BVDV during early gestation may cause abortion or birth of calves immunologically tolerant to the infecting virus. 12, 17 These calves are persistent carriers of BVDV and can be a source of infection to the herd. 4 Superinfection of persistently infected cattle with a cytopathic BVDV may induce mucosal disease. 4,7 Detection of persistently infected cattle is important for control of BVD. In addition, contamination of fetal bovine serum and other bovine products used in cell culture work with BVDV presents a problem in preparing veterinary biologics. 3, 19 Traditionally, virus isolation with confirmation by immunofluorescence has been the method used to detect BVDV in clinical samples and in contaminated cell cultures and biological products. These techniques are time consuming and require the use of cell culture. Several reports have described rapid diagnostic tests for BVDV
Materials and Methods
Preparation of clinical samples. Tissue samples from cattle with clinical signs of BVD were submitted to the University of Nebraska Veterinary Diagnostic Center virology laboratory. All samples came from the state of Nebraska between 1988 and 1990. The samples were prepared as follows. Minimum essential medium (MEM) with 2% horse serum was added to tissue at a ratio of 3:l and then homogenized in a stomacher for 2-4 min. The homogenate was centrifuged at 2,000 rpm for 30 min at 4 C, after which the supernatant was poured into 15-ml snap cap tubes. After initial detection of BVDV by virus isolation, homogenates were preserved by freezing at -70 C.
Cell cultures. Tissue homogenates were inoculated onto primary bovine lung cells and bovine turbinate cells a that were free of BVDV. Cultures were maintained in MEM supplemented with 10% horse serum in Leighton tubes. Cell monolayers were stained for BVDV antigen using fluorescein-labeled antibody a and examined by fluorescent microscopy. Tissue homogenates that were positive for BVDV were used for further analysis by PCR.
Titration of homogenates. Before the PCR was used, the titer of infectious BVDV was determined using microtitration plates and bovine lung cells. For noncytopathic BVDV samples, serial dilutions of virus were inoculated onto bovine lung cells and then infected with a cytopathic BVDV (Singer strain). End point was determined by observing inhibition of cytopathic effect?
Primers for PCR. The primers used in this study are listed in Table 1 . Primer set 1 15 amplifies a 205-base segment that contains a BstIII site. The primers were synthesized b and purified by either polyacrylamide gel electrophoresis (PAGE) or high-performance liquid chromatography (HPLC). A second set of primers was used on samples that were not amplified by primer set 1 with the exception of 3 samples that lacked sufficient quantity for testing. These primers are located at the 5' end immediately upstream of the open reading frame. 22 Extraction of BVDV RNA from tissue homogenates. A 100-µl volume of tissue homogenate was added to 450 µ1 of STE buffer (100 mM NaCl, 50 mM Tris, 5 mM ethylenediaminetetraacetic acid [EDTA]; pH 8) in a microcentrifuge tube. Proteinase K was added at a concentration of 20 µg/ ml, the solution was incubated at room temperature for 10 min, and 6 µl of 10% sodium dodecyl sulfate (SDS, 0.2% wt/ vol) was added. After incubation at 56 C for 20 min, phenol/ chloroform extractions were done, and the nucleic acid was precipitated with 60 µl of 3 M sodium acetate (pH 5.2) plus 1 ml cold (-20 C) 100% ethyl alcohol. The precipitated RNA was pelleted by centrifugation for 15 min at 12,000 x g at 4 C, washed with cold 70% ethanol, and dried in a vacuum desiccator.
Reverse transcription (R T). After resuspension of the RNA pellet in 9 µl of sterile distilled water, 1 µl (40 µmol) of each primer was added and the sample was incubated for 5 min at 70 C. The sample was chilled on ice for 1 min and 3 µl of deoxynucleoside triphosphates c (7.5 µM), 4 µl Schimke solution (10 mM dithiothreitol, 10 mM MgCl,, 70 mM KCl, 80 mM Tris; pH 8), 1 µl of reverse transcriptase d (19.6 u/ml), and 1 µl of RNase inhibitor e (28 u/µl) were added. The resulting RT reaction mixture was incubated at 42 C for 2 hr. Reaction mixtures were then chilled on ice for immediate testing or stored at -20 C.
PCR. Viral strains NADL and Singer were used as positive controls for PCR. Negative controls consisted of MEM with 1) 10% horse serum and gentamicin and 2) tissue homogenate from a gnotobiotic calf. A mixture of PCR reagents without template was used as control for detection of contamination with extraneous DNA.
A master mix was made of the following reagents: distilled water, 58.5 µl; 10x buffer, 9.5 µl (15 mM MgCl 2 , 400 mM Tris-HCl, 500 mM KCl, 1% gelatin); dNTPS, 16 µl of equimolar mixture of dNTPs (5 mM); 3 µl (40 µmol) of each primer. A 5-µl aliquot of RT reaction mixture was added; the resulting mixture was heated to 95 C for 5 min and chilled on ice. Then 2.5 units of Taq polymerase e in 5 µl of 1 x buffer (10 x Promega buffer diluted 1: 10) were added for PCR amplification. A layer of 60 µl of Nujol mineral oil f was added.
The PCR program consisted of 1 min at 95 C (denaturation), 1 min at 55 C (primer annealing) and 2 min at 72 C (primer extension) for 40 cycles. Primer set 2 was used at a concentration of 15 µmol per reaction during both RT and PCR. All other parameters remained as previously described.
Nucleic acid hybridization. PCR products using primer set 1 were analyzed by electrophoresis in 2% agarose g in TBE buffer (0.045 M Tris borate, 0.001 M EDTA). Gels were blotted onto a nylon membrane, denatured, and cross-linked by UV light. The hybridization reaction used a 30-base probe with the following sequence: ACCTAAACCGAAGCAGGT-TACCAAGGAAGC. The probe was end labeled with 32 P using T4 polynucleotide kinase. h Unincorporated label was removed by chromatography using a Sephadex G-50 spin column. Prehybridization was done in 5 x SSPE-1 x BP (2% bovine serum albumin, 2% polyvinylpyrrolidone)-1% sodium dodecyl sulfate (SDS) for 30 min at 55 C. The hybridization was performed using the same buffer with addition of at least 4 x 10 6 cpm probe/ml for 0.5 hr at 55 C. The nylon filter was washed in 1% SSPE-1% SDS 3 times for 5 min at room temperature and 1 time for 1 min at 55 C. The filter was dried, exposed to radiographic film, and developed.
Analysis of the amplified product from primer set 2 was performed using a probe made from a 365-base pair segment of the BVDV-Singer genome' and cloned into the pBluescript II KS +/-vector j The probe aligned with bases 182-545 of the BVDV NADL genome. Phage T3 polymerase with 32 P-UTP was used to radiolabel the probe.
Prehybridization was for at least 4 hr at 55 C in hybridization buffer consisting of 6 x standard saline citrate (SSC), 2 x Denhardt's reagent, 0.1% SDS, and 100 u/ml denatured salmon sperm. Hybridization with the same buffer was done at 55 C overnight. The blots were washed twice for 5 min at room temperature in 1 x SSC and 0.1% SDS followed by 2 washes for 30 min in 0.2 x SSC and 0.1% SDS at 55 C. Autoradiography was performed by exposing the blot to radiographic film.
Results

Titration of BVDV infectivity in clinical samples.
Fifty-five of 60 tissue homogenates had sufficient quantity to be tested for virus concentration. In 23 homogenates, the concentration of BVDV (either cytopathic or noncytopathic) was 10 1.7 -10 3.3 CCID,,/ml. The concentration of BVDV in 32 homogenates was < 10 1.7 CCID 50 /ml PCR results using primer sets 1 and 2. Using PCR primer set 1, 46/60 homogenates (77%) were positive for BVDV (Table 2) . Forty-six isolates were positive by PCR using the UNL primers, for a detection level of 77% (46/60). Primer set 2 allowed detection of BVDV in 10/11 homogenates that were negative using primer set 1. These complementary primers boosted the detection level to 93% (56/60).
Discussion
Practical application of PCR for diagnosis of BVDV requires that it be useful for field samples such as tissue homogenates. Consideration should be given to the sensitivity of the test and ability of the primers to identify most, if not all, BVDV strains. In this study, PCR was evaluated for direct detection of BVDV in tissue homogenates from field cases of BVD. Using 2 sets of primers, 55/60 tissue homogenates positive for BVDV by virus isolation were positive by PCR. The PCR procedure used here required a single amplification cycle and used primers derived from either the 5' noncoding region or the 3' coding region of the viral genome.
In an earlier study, a PCR technique was evaluated on tissue samples without cell culture passage. 2 These authors tested their set of nested primers targeting the genomic region of gp48 on 8 organ suspensions positive for BVDV by virus isolation. They were able to detect BVDV in the suspensions only after second stage amplification by PCR.
In the present study, primer set 2 detected 3 samples that had detectable virus titer but were negative with primer set 1. Primer set 2 may amplify a more conserved area of the BVDV genome. The genomic diversity of BVDV is well documented and presents a challenge to researchers looking for a nucleic acid-based test that will detect all isolates. 13, 14, 22 Further work in the development of a diagnostic PCR procedure for detection of BVDV should focus on the selection of a single universal set or mixture of primers that can detect all strains of BVDV. Also, re-et al. sitivity of PCR as a diagnostic test. 16 Routine use of PCR in a diagnostic setting will require the use of nonradioactively labeled oligonucleotide probes in confirmatory hybridizations of amplified products.
